Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: A meta-analysis

American Journal of Gastroenterology

Volumn 107, Issue 4, 2012, Pages 507-520

  Barkun, Alan N ^a   Bardou, Marc ^b,c   Pham, C Q D ^d,e   Martel, Myriam ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE BOURGOGNE   (France)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; SUCRALFATE; TEPRENONE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; DRUG EFFICACY; HUMAN; MEDICAL LITERATURE; META ANALYSIS; MORTALITY; MUCOSAL BLEEDING; NOSOCOMIAL PNEUMONIA; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; RISK FACTOR; STRESS RELATED MUCOSAL BLEEDING; SYSTEMATIC REVIEW;

CRITICAL ILLNESS; GASTROINTESTINAL HEMORRHAGE; HISTAMINE H2 ANTAGONISTS; HUMANS; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STRESS, PSYCHOLOGICAL;

EID: 84859577697     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.474     Document Type: Article

References (39)

1. Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 2008;135:41-60. (Pubitemid 351899027)
2. Laine L, Curtis SP, Langman M et al. Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. Gastroenterology 2008;135:1517-25.
3. Spirt MJ. Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther 2004;26:197-213. (Pubitemid 38339012)
4. Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care 2005;20:35-45. (Pubitemid 40602222)
5. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309:1286-91. (Pubitemid 24340510)
6. Higgins JPT, Green S (eds). Assessment of Study Quality. Cochrane Handbook for Systematic Reviews of Interventions updated March 2011; version 5.1.0.
7. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-74.
8. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58. (Pubitemid 34746062)
9. Friedrich JO, Adhikari NK, Beyene J. Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data. BMC Med Res Methodol 2007;7:5.
10. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004;23:1351-75. (Pubitemid 38594143)
11. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
12. Egger M, Davey Smith G, Schneider M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. (Pubitemid 27387172)
13. Hejazi RA, S alehi M. Stress ulcer prophylaxis with ranitidine and omeprazole in patients on mechanical ventilation, a randomized placebo controlled trial. GUT 2006;55 (Suppl V):A47.
14. Moher D, Cook DJ, Eastwood S et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354:1896-900.
15. Somberg L, Morris J Jr, Fantus R et al. Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease. J Trauma 2008;64:1202-10.
16. Conrad SA, Gabrielli A, Margolis B et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension vs. intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 2005;33:760-5.
17. Kantorova I, Svoboda P, Scheer P et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology 2004;51:757-61. (Pubitemid 38590958)
18. Levy MJ, Seelig CB, Robinson NJ et al. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 1997;42:1255-9. (Pubitemid 27343453)
19. Powell H, Morgan M, Li SK et al. Inhibition of gastric acid secretion in the intensive care unit after coronary artery bypass graft. A pilot control study of intravenous omeprazole by bolus and infusion, ranitidine and placebo. Theor Surg 1993;8:125-30. (Pubitemid 23237641)
20. Hata M, Shiono M, Sekino H et al. Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery. Circ J 2005;69:331-4. (Pubitemid 40410190)
21. Solouki MMSK, Mokhtari M, Nasiri E. Comparison between the preventive effects of ranitidine and omeprazole on upper gastrointestinal bleeding among ICU patients. Tanaffos 2009;8:37-42.
22. Brophy GM, Brackbill ML, Bidwell KL et al. Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients. Neurocrit Care 2010;13:176-81.
23. Pan X, Zhang W, Li Z et al. The preventive effects of rabeprazole on upper gastrointestinal tract hemorrhage in patients with severe acute pancreatitis. Chinese J Gastroenterol 2004;9:30-2. (Pubitemid 38519489)
24. De Azevedo JR, Soares MG, Silva GAE et al. Prevention of stress ulcer bleeding in high risk patients. Comparison of three drugs. GED 2000;19:239-44. (Pubitemid 32167544)
25. Phillips JO, Metzler MH, Huckfeldt RE et al. A multicenter, prospective, randomized clinical trial of continuous I.V. ranitidine vs. omeprazole suspension in the prophylaxis of stress ulcer prophylaxis (abstract). Crit Care Med 1998;26:A101. (Pubitemid 128778506)
26. Fink MKR, Maroko R, Field B. Intravenous pantoprazole and continuous infusion cimetidine prevent upper gastrointestinal bleeding regardless of II APACHE score in high risk intensive care unit patients. Gastroenterology 2003;124:A625.
27. Morris J, Karlstadt R, Blatcher D et al. Intermittent intravenous pantoprazole rapidly achieves and maintains gastric pH &γε;4.0 compared with continuous infusion H2-receptor antagonist in intensive care unit patients. Crit Care Med 2001;29:A147.
28. Vorder Bruegge WF, Peura DA. Stress-related mucosal damage: review of drug therapy. J Clin Gastroenterol 1990;12 (Suppl 2):S35-40. (Pubitemid 20378658)
29. Barkun AN, Cockeram AW, Plourde V et al. Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 1999;13:1565-84. (Pubitemid 30009074)
30. Marik P, Vasu T, Hirani A et al. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis. Crit Care Med 2010;38:2222-8.
31. Cook D, Heyland D, Griffith L et al. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. Crit Care Med 1999;27:2812-7. (Pubitemid 30027202)
32. Muller T, Barkun AN, Martel M. Non-variceal upper GI bleeding in patients already hospitalized for another condition. Am J Gastroenterol 2009;104:330-9.
33. Laterre PF, Horsmans Y. Intravenous omeprazole in critically ill patients: a randomized, crossover study comparing 40 with 80 mg plus 8 mg/h on intragastric pH. Crit Care Med 2001;29:1931-5. (Pubitemid 32980404)
34. Kedika RR, Souza RF, Spechler SJ. Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci 2009;54:2312-7.
35. Lau JY, Leung WK, Wu JC et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med 2007;356:1631-40. (Pubitemid 46631672)
36. Cook DJ, Reeve BK, Guyatt GH et al. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 1996;275:308-14.
37. Lin PC, Chang CH, Hsu PI et al. The efficacy and safety of proton pump inhibitors vs. histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Crit Care Med 2010;38:1197-205.
38. Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Stat Med 2002;21:1575-600. (Pubitemid 34746064)
39. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis: enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia - a post hoc analysis from the Cochrane Collaboration. Aliment Pharmacol Ther 2005;21:1055-61. (Pubitemid 40646530)